Dr. Martens (LON:DOCS) Insider Ije Nwokori Buys 167 Shares

Key Points

• Insider Ije Nwokori purchased 167 shares of Dr. Martens at an average price of GBX 89 per share, totaling £148.63.
• Dr. Martens currently has a market capitalization of £847.37 million and a debt-to-equity ratio of 127.27.
• Analysts have a consensus rating of "Hold" on Dr. Martens, with Peel Hunt recently upgrading the stock to a "buy" rating.

Dr. Martens plc (LON:DOCS - Get Free Report) insider Ije Nwokori bought 167 shares of the stock in a transaction on Monday, October 13th. The shares were bought at an average cost of GBX 89 per share, with a total value of £148.63.

Ije Nwokori also recently made the following trade(s):

• On Wednesday, October 8th, Ije Nwokori acquired 136 shares of Dr. Martens stock. The stock was acquired at an average cost of GBX 90 per share, with a total value of £122.40.
• On Monday, August 11th, Ije Nwokori acquired 194 shares of Dr. Martens stock. The stock was acquired at an average cost of GBX 77 per share, with a total value of £149.38.

Dr. Martens Trading Down 1.3%

LON DOCS opened at GBX 87.75 on Tuesday. The firm has a 50 day simple moving average of GBX 88.47 and a 200-day simple moving average of GBX 73.27. The company has a debt-to-equity ratio of 127.27, a quick ratio of 1.13 and a current ratio of 2.85. Dr. Martens plc has a one year low of GBX 43.02 and a one year high of GBX 100.87. The firm has a market cap of £847.37 million, a price-to-earnings ratio of 17,550.00, a PEG ratio of 6.40 and a beta of 0.11.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on DOCS shares. Peel Hunt raised shares of Dr. Martens to a "buy" rating in a report on Monday, August 18th. Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating on shares of Dr. Martens in a report on Friday, July 11th. One research analyst has rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus price target of GBX 6,000.

Dr. Martens Company Profile

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.